Aprameya Engineering Ltd
Aprameya Engineering Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY25 call signalled
3 of 5 strong
The short version
Aprameya aims to achieve sustained growth faster than the healthcare infrastructure industry's CAGR of 22% over the last decade. Aprameya aims to sustain strong growth, leveraging proprietary turnkey projects and expanding services.
From Aprameya Engineering Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Aprameya aims to achieve sustained growth faster than the healthcare infrastructure industry's CAGR of 22% over the last decade.
- The company is optimistic about securing good orders across multiple states due to its proprietary products and strong entry barriers in tenders.
- With an expanding geographic footprint into states like Bihar, Uttarakhand, Assam, Chhattisgarh, Daman, and Sikkim, Aprameya is positioned for scalable growth.
- Order book stood at INR 60 crores, with expectations for continuous order inflow driven by unique, lifesaving proprietary solutions.
- Revenue grew by 108% YoY to INR 136 crores in FY25, backed by a higher share of high-margin turnkey projects.
2 more points from Aprameya Engineering Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Aprameya Engineering Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Capex for expansion into new states will be gradual, not a one-time large investment; focus is on brownfield projects (working inside existing buildings) rather than greenfield projects.
- Capital investments in new states will be phased over 2-3 months per project rather than upfront heavy capital.
- The company plans to control capex carefully to avoid hampering cash flow and maintain a balanced inflow and outflow ratio.
- Specific capex figures are not shared publicly; investors are encouraged to contact the IR agency for detailed queries.
2 more points from Aprameya Engineering Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Aprameya Engineering Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Current order book: Approximately INR 60 crores.
- Execution timeline: Orders expected to be completed within 5 to 6 months.
- Geographic split: 60%-70% from Maharashtra, 10%-20% from Rajasthan, remaining from Gujarat.
- Growth outlook: Company optimistic about securing additional orders due to sector growth and strong entry barriers.
2 more points from Aprameya Engineering Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Continue your research
What Aprameya Enginee's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Vaidya Sane (Q4 FY25)
120 crores. Key concall takeaways from Vaidya Sane Ayurved Laboratories Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Poly Medicure Ltd (Q4 FY25)
EBITDA margins guided between 25%-27%, with potential upside if export growth exceeds 15%. Key concall takeaways from Poly Medicure Ltd's Q4 FY25 earnings call…
- OSEL Devices (Q4 FY25)
Current order-in-hand for OSEL Devices Limited is approximately INR 40-45 crores. Key concall takeaways from OSEL Devices Ltd's Q4 FY25 earnings call — and how…
- Prevest Denpro (Q4 FY25)
The management emphasizes growth in both domestic and export markets, indicating healthy order inflows aligned with a 13% sales increase in FY25. Key concall…
Arthneeti Pro · Annual
Aprameya Engineering Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Aprameya Engineering Ltd Q4 FY25 results?
Aprameya aims to achieve sustained growth faster than the healthcare infrastructure industry's CAGR of 22% over the last decade. Aprameya aims to sustain strong growth, leveraging proprietary turnkey projects and expanding services.
What is Aprameya Engineering Ltd share price analysis?
Aprameya Engineering Ltd currently shows a below-average growth signal. The stock trades at a P/E of 52.8 with a market cap of ₹266 Cr. Investors should review the full earnings analysis for detailed insights.
Is Aprameya Engineering Ltd planning capital expenditure?
Capex for expansion into new states will be gradual, not a one-time large investment; focus is on brownfield projects (working inside existing buildings) rather than greenfield projects.
Keep Aprameya Engineering Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.